Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine

A Phase I/III clinical trial was conducted, focusing on an adsorbed tetanus vaccine. The study aimed to investigate conditions related to tetanus and the efficacy of the tetanus vaccine itself. The intervention involved a biological preparation, specifically adsorbed tetanus toxoid. Beijing Minhai Biotechnology Co., Ltd was the sponsor of this clinical study. The trial has been successfully completed.